 |
L-R: Dr Sara Prickett, Professor Robyn O’Hehir and Emeritus Professor Jenny Rolland have hworked together for years on the peanut allergy research and are co-founders of Aravax P/L. |
A new peanut allergy treatment developed by Monash researchers is now beginning clinical trials in Melbourne and Adelaide. If you would like to participate, see contact details at:
www.aravax.com.au/product-development.html
Professor Robyn O’Hehir is Professor/Director of the Department of Allergy, Immunology and Respiratory Medicine at Alfred Health and Monash University. Her research team, co-led by Professor Jennifer Rolland, over several years identified the critical components of the peanut allergy therapy now being developed by Aravax, an Australian spinout biotechnology company.